Prostate cancer: who is at risk and how to catch it early

Prostate cancer: who is at risk and how to catch it early

Julie Scott, DNP
Julie Scott, DNP

What is Prostate cancer?

Prostate cancer is common cancer in men. About 13% of men will be diagnosed with prostate cancer during their lifetime. It’s important to know that prostate cancer is very treatable, even in its advanced stages. 

Risk Factors

The biggest risk factor men face for prostate cancer is age. It’s rarely diagnosed in men under 40, with the average age at diagnosis of 66 years. In addition to age, other risk factors for developing prostate cancer include being of African American or Caribbean ancestry and having a father or brother who has had prostate cancer. 

Diagnosis

The prostate-specific antigen (PSA) is a simple blood test that can be done to help detect prostate cancer at an early stage. There is not one specific level that officially diagnoses prostate cancer. Still, it can be followed as a trend over time, with an increasing PSA being more likely to be caused by prostate cancer. 

PSA can fluctuate over time and can be elevated due to factors unrelated to prostate cancer. If a man is suspected of having prostate cancer, another testing will need to be done. 

A prostate biopsy will ultimately need to be done to diagnose someone with the disease. There are multiple ways the biopsy can be done, but typically biopsies are taken from multiple areas of the prostate for evaluation. 

Imaging tests such as ultrasound, MRI, CT scan, and PET scan can be done to assess the extent of the disease and provide staging information to see if the cancer is only in the prostate or has spread into lymph nodes or distant areas of the body. 

Treatment

There are multiple treatment options for prostate cancer, and which ones are used depends upon many factors. 

Some men won’t have any treatment, and will be appropriate for “watchful waiting”, and will be followed with imaging and labs every few months, only to be treated if or when the cancer progresses. 

Surgical removal of the prostate may be recommended for some but not all men with prostate cancer. 

Radiation is a commonly used treatment, and can be given through external beam radiation, or brachytherapy. Brachytherapy is the placement of seeds containing radiation directly into the prostate to treat the cancer. 

Hormone suppression is often given for prostate cancer as well. Testosterone is a fuel for the prostate cancer cells to grow, so decreasing the amount of testosterone in the body can help treat the cancer.  

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Financial Transparency and Patient Experience
April 3, 2023

The patient experience related to financial transparency during cancer treatment is critical in ensuring that patients receive the best possible care and can manage the financial burden associated with cancer treatment. This experience can impact how patients perceive the cost of treatment, their ability to make informed decisions if they…

Jenni Daniel BSN, RN

author

Articles
Understanding Myeloproliferative Neoplasm and Its Treatment Options
January 23, 2023

What are Myeloproliferative neoplasms (MPNs) Myeloproliferative neoplasms (MPNs) are a group of blood cancers that affect the bone marrow and the blood cells it produces. They lead to the abnormal growth of one or more types of blood cells that the bone marrow produces, including white blood cells, red blood…

Julie Scott, DNP

author

Articles
What You Need to Know and How to Help Someone Diagnosed with Inflammatory Breast Cancer
January 23, 2023

What is Inflammatory breast cancer (IBC)? Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. It is known by the inflammation of the breast tissue. IBC is a rare form of breast cancer, accounting for only 1-5% of all breast cancer cases. It’s caused by the…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice